top of page
Immanuel Lerner
Co-Founder & CEO of Pepticom
I co-invented, founded and currently I am leading Pepticom, a disruptive company in the field of AI-based peptide drug discovery/design. I led Pepticom from concept to revenue generation via collaboration with large multinational companies, negotiated and executed discovery deals and seed/Round A finance. My 15-year academic career prior to the establishment of Pepticom includes a Ph.D. in biochemistry followed by postdoctoral research at the Hebrew University of Jerusalem. During my studies, I published research in leading journals and had the honor of publishing my postdoc research with the 2017 Nobel Laureate in Physiology/Medicine Prof. Michael Rosbash.



Speakers

















































bottom of page